Search
for
Sort by
Research 31–60 of 1000+
- Review of Drug Repositioning in Cancer Therapeutics
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Clinical efficacy and safety of Kanglaite injection, adjuvant cemcitabine and cisplatin chemotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- Erosive Pustular Dermatosis of the Scalp-Like Eruption due to Gefitinib: Case Report and Review of the Literature of Alopecia Associated with EGFR Inhibitors
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- Erlotinib induced acneiform eruption: A case report
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Prevention of erlotinib-induced folliculitis with doxycycline
- Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
- A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- “PRIDE” Complex
- Gefitinib: an adverse effects profile
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Formulation of Chitosan-Coated Brigatinib Nanospanlastics: Optimization, Characterization, Stability Assessment and In-Vitro Cytotoxicity Activity against H-1975 Cell Lines
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Proliferation, but Not Apoptosis, Is Associated with Distinct β-Catenin Expression Patterns in Non-Small-Cell Lung Carcinomas
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Radioprotection of Lung Tissue by Soy Isoflavones
- Characters of KRT80 and its roles in neoplasms diseases
- Gefitinib
- Patient experience with later line chemotherapy in four tumor types.